Shannon M. Reilly has dedicated her career to studying metabolic health and disease. During her doctoral studies at Harvard’s TH Chan School of Public Health, Dr. Reilly investigated the transcriptional networks that contribute to obesity related metabolic diseases. As a postdoctoral fellow in Alan Saltiel’s laboratory at the University of Michigan, Dr. Reilly characterized the signaling pathways linking adipose tissue inflammation to metabolic disease. Dr. Reilly is now an Assistant Professor at Weill Cornell Medicine, studying catabolic metabolism in catecholamine-stimulated adipocytes. She has discovered that upon stimulation of lipolysis, adipocytes suppress fatty acid re-esterification and promote oxidative metabolism, thereby increasing energy expenditure.